HLB bioStep Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	49,230	122,820	176,390	242,875	327,966	219,226
Market Cap Growth	-63.98%	-30.37%	-27.37%	-25.95%	49.60%	14.63%
Enterprise Value	53,971	134,125	168,104	226,210	341,037	227,757
Last Close Price	2860.00	7270.00	10475.00	15450.00	23250.00	15846.21
PE Ratio	-	-	-	-	-	19.87
PS Ratio	0.67	1.66	3.03	4.60	3.80	3.40
PB Ratio	0.46	1.22	1.51	2.35	4.54	3.30
P/TBV Ratio	0.50	1.34	1.73	2.43	4.79	3.50
P/FCF Ratio	-	110.34	-	204.19	206.70	-
P/OCF Ratio	-	39.80	-	46.78	50.61	25.90
EV/Sales Ratio	0.73	1.81	2.89	4.28	3.95	3.54
EV/EBITDA Ratio	-	-	-	98.80	36.23	18.93
EV/EBIT Ratio	-	-	-	-	64.24	25.29
EV/FCF Ratio	-	120.50	-	190.18	214.94	-
Debt / Equity Ratio	0.29	0.31	0.30	0.59	1.27	0.25
Debt / EBITDA Ratio	-	-	-	26.48	9.74	1.35
Debt / FCF Ratio	-	27.64	-	50.98	57.76	-
Net Debt / Equity Ratio	0.00	-0.12	-0.10	-0.09	-0.07	0.09
Net Debt / EBITDA Ratio	-0.04	3.22	1.46	-4.25	-0.58	0.49
Net Debt / FCF Ratio	-0.04	-11.30	0.59	-8.19	-3.42	-0.53
Asset Turnover	0.47	0.46	0.34	0.31	0.65	0.76
Inventory Turnover	11.24	12.09	11.33	10.96	14.15	8.80
Quick Ratio	0.95	1.07	1.20	1.15	8.36	1.14
Current Ratio	1.20	1.26	1.35	1.23	8.57	1.75
Return on Equity (ROE)	-18.40%	-18.60%	-8.80%	-0.06%	-1.27%	19.00%
Return on Assets (ROA)	-3.47%	-3.33%	-4.80%	-0.43%	2.49%	6.67%
Return on Invested Capital (ROIC)	-8.88%	-8.95%	-13.15%	0.25%	7.64%	13.51%
Return on Capital Employed (ROCE)	-7.60%	-8.00%	-10.70%	-1.10%	3.30%	11.50%
Earnings Yield	-39.16%	-15.44%	-4.86%	-0.07%	-0.31%	5.03%
FCF Yield	-8.73%	0.91%	-11.68%	0.49%	0.48%	-5.08%
Payout Ratio	-	-	-	-	-	10.26%
Buyback Yield / Dilution	44.94%	-0.68%	-9.45%	-9.59%	-0.02%	-1.35%